Kirloskar Oil Engines Limited (KIRLOSENG)
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation - Q2 FY27
- Standalone revenue from operations grew 19% y-y to ₹1,739 Cr; EBITDA margin declined to 11.0% from 14.0% y-y
- Consolidated revenue from operations rose 17% y-y to ₹2,284 Cr; PAT from continuing operations down 18% y-y
- Strong domestic Powergen segment growth with increased market share in MHP and HHP segments
- International business recovery led by Africa market growth
- Fluid Dynamics segment showed significant revenue recovery with robust domestic and export volume growth
- Financial Services segment saw stable loan book and AUM with focus on secured retail growth
- Net cash position improved; working capital days stable
- Q2 FY27 earnings call scheduled for 5th Nov 2026 at 1:30 pm IST
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 KIRLOSENG — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add KIRLOSENG to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Kirloskar Oil Engines Limited
Important.
The summary above is generated automatically from Kirloskar Oil Engines Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.